📄 "The Many Faces of Primary EBV Infection: A Case Series of Its Diverse Presentations" . EBV ( December 30, 2025 at 10:37AM)
https://pubmed.ncbi.nlm.nih.gov/41464649/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20251230083742&v=2.18.0.post22+67771e2

📄 "Clinicopathological Study of Hodgkin Lymphoma in Relation to Programmed Death-Ligand 1 (PD-L1) Expression and Epstein-Barr Virus (EBV) Status" . Vírus e Câncer ( January 1, 2026 at 11:48AM)
https://pubmed.ncbi.nlm.nih.gov/41477414/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260101094853&v=2.18.0.post22+67771e2

📄 "Epstein-Barr Virus Promotes Gastric Cancer Progression by Modulating m6A-Dependent YTHDF1-TSC22D1 Axis" . ⭐ Virus and Cancer Progression ( December 31, 2025 at 12:47PM)
https://pubmed.ncbi.nlm.nih.gov/41472023/?utm_source=Feedly&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1ru3PjCROMN0-DCYXXwG3ZQiiaCRebQ72s7IemRCfW7HQFT5bF&fc=20250206153036&ff=20251231104714&v=2.18.0.post22+67771e2

📄 "Discoveries beyond molecular mimicry describe how EBV drives multiple sclerosis" . EBV ( January 24, 2026 at 02:59AM)
https://pubmed.ncbi.nlm.nih.gov/41576916/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260124005911&v=2.18.0.post22+67771e2

📄 "Cat viruses as windows into human oncogenesis" . Nature Rev Cancer ( January 23, 2026 at 06:32PM)
https://www.nature.com/articles/s41568-026-00909-z

📄 "Epstein-barr virus latent membrane protein 1 targets cIAP1, cIAP2 and TRAF2 for proteasomal degradation to activate the non-canonical NF-kappaB pathway" . EBV ( January 26, 2026 at 08:24PM)
https://pubmed.ncbi.nlm.nih.gov/41587214/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260126182420&v=2.18.0.post22+67771e2

📄 "KSHV and cancer: understanding the oncogenic machinery for next-generation diagnostic tools and therapies" . KSHV/HHV-8 ( January 21, 2026 at 03:49PM)
https://pubmed.ncbi.nlm.nih.gov/41563473/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0MbwdG8oCHuS3zShObm9OxM2igUrv8WmS1-6Xt5ghCU&fc=None&ff=20260121134907&v=2.18.0.post22+67771e2

📄 "Expanding the Global Landscape of Epstein-Barr Virus Genomes: A Call for Greater Representation" . EBV ( January 12, 2026 at 04:36PM)
https://pubmed.ncbi.nlm.nih.gov/41524218/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260112143559&v=2.18.0.post22+67771e2

📄 "Profiling and functional analysis of exosomal circRNAs from EBV-associated gastric carcinoma CSCs" . EBV ( January 8, 2026 at 10:56PM)
https://pubmed.ncbi.nlm.nih.gov/41504772/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260108205620&v=2.18.0.post22+67771e2

📄 "Clinicopathologic Analysis of 34 Japanese Patients With EBV-Associated Reactive Lymphoid Hyperplasias" . EBV ( January 7, 2026 at 04:44AM)
https://pubmed.ncbi.nlm.nih.gov/41495022/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260107024409&v=2.18.0.post22+67771e2

📄 "Scraps of viral DNA in biobank samples reveal secrets of Epstein-Barr virus" . EBV ( January 29, 2026 at 04:49AM)
https://pubmed.ncbi.nlm.nih.gov/41606359/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260129024950&v=2.18.0.post22+67771e2

📄 "Population-scale sequencing resolves determinants of persistent EBV DNA" . EBV ( January 29, 2026 at 04:49AM)
https://pubmed.ncbi.nlm.nih.gov/41606327/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260129024950&v=2.18.0.post22+67771e2

📄 "A threshold in anti-EBNA-1 antibody titers distinguishes salivary EBV shedders from non-shedders" . EBV ( January 6, 2026 at 10:28PM)
https://pubmed.ncbi.nlm.nih.gov/41493209/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260106202816&v=2.18.0.post22+67771e2

📄 "Chronic Active Epstein-Barr Virus Disease: Molecular Pathogenesis, Evolving Concepts, and Emerging Therapies" . EBV ( January 6, 2026 at 04:07PM)
https://pubmed.ncbi.nlm.nih.gov/41490284/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260106140734&v=2.18.0.post22+67771e2

📄 "The Biology and Clinical Utility of EBV Monitoring in Blood" . EBV ( February 3, 2026 at 06:01PM)
https://pubmed.ncbi.nlm.nih.gov/41632221/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260203160139&v=2.18.0.post22+67771e2

📄 "Epstein-Barr Virus Infection at Single-Cell Resolution" . EBV ( February 5, 2026 at 08:29PM)
https://pubmed.ncbi.nlm.nih.gov/41641929/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260205182942&v=2.18.0.post22+67771e2

📄 "Establishment of an Epstein-Barr virus infection model using human nasal organoids" . EBV ( February 4, 2026 at 08:30AM)
https://pubmed.ncbi.nlm.nih.gov/41633691/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260204063001&v=2.18.0.post22+67771e2

📄 "Research on EBV-miR-BART17-5p targeted Inhibition of ARID1A expression to regulate nasopharyngeal carcinoma dedifferentiation" . EBV ( February 14, 2026 at 08:45AM)
https://pubmed.ncbi.nlm.nih.gov/41689061/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260214064459&v=2.18.0.post22+67771e2

📄 "Long noncoding RNA ADEI/miR-93-3p/STAT3 axis promotes Epstein-Barr virus-positive diffuse large B-cell lymphoma progression and immune evasion through regulating the PD-1/PD-L1 checkpoint" . Vírus e Câncer ( March 4, 2026 at 06:15AM)
https://pubmed.ncbi.nlm.nih.gov/41775689/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260304041531&v=2.19.0.post6+133c1fe

📄 "Epstein-Barr virus-associated lymphoma: current understanding and treatment strategies" . Vírus e Câncer ( March 7, 2026 at 08:33PM)
https://pubmed.ncbi.nlm.nih.gov/41793645/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0u90aheep466_8QQJ_eCsFFK8hoDV096ilWAIPckjVx&fc=None&ff=20260307183311&v=2.19.0.post6+133c1fe

📄 "EBV-dUTPase Modulates Host Immune Responses Potentially Altering the Tumor Microenvironment in EBV-associated Malignancies" . EBV ( March 16, 2026 at 08:17AM)
https://pubmed.ncbi.nlm.nih.gov/41835621/?utm_source=Feedly&utm_medium=rss&utm_campaign=None&utm_content=0QA_9LuQeZiNtqHBsduJlC5R9OwbuQKm4WoBORUOvGl&fc=None&ff=20260316071705&v=2.19.0.post6+133c1fe